1. production of fine chemicals and pharmaceuticals
(Blog/blog)

Can ultrasound be used for continuous crystallisation manufacturing techniques ensure consistent crystal properties (size, distribution and morphology) and better filtration rates in the production of ...

2. November 3-4, 2010: Crystallization & Polymorphism, Florida
(events/events)

... (habit, solvate, polymorph) and particle size. For further details please refer to: http://www.scientificupdate.co.uk/conferences/scheduled-conferences/details/89-Polymorphism-and-Crystallization.html ...

3. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

... Dose Inhalation (pMDI). Particles for inhaled medicines can be manufactured with the optimal performance attributes of size, shape, surface rugosity, low surface free energy, crystallinity and stability. ...

4. Product Pipeline - Making Better Medicines
(Pharmaceuticals/Pharmaceuticals)

... exhibiting poor aqueous solubility where particle size and morphology control is a very important consideration.   Prosonix welcomes enquiries from all parties interested in licensing and co-development ...

5. Prosonix Wins Award at Major Conference- DDL-20
(News/Latest)

... area of pharmaceutical science. Given the fact that the poster sessions at DDL-20 were peer reviewed, this success once again emphasizes that Prosonix is now truly participating at ...

6. Prosonix Wins Poster Award at DDL-20
(News/Newsflash)

... area of pharmaceutical science. Given the fact that the poster sessions at DDL-20 were peer reviewed, this success once again emphasizes that Prosonix is now truly participating at the highest ...

7. Ultrasound
(slider/slider)

... of particle size, morphology, polymorphism, crystallinity and purity, and in doing so helps eliminate the need for troublesome external seeding and micronization for inhaled medicines.  ...

8. Particles
(slider/slider)

ProsonitronTM, DISCUS®, SAXTM,  UMAX® SAXTM  and PRT based process technologies are proprietary "Solution-to-Particle" methods for controlling crystal size, shape and polymorph for APIs and helping ...

9. SonoLab
(technology/Technology)

... with novel transducer based design, allows reproducible control of crystallization processes, enabling selectivity of parameters such as particle size, shape, crystallinity and polymorphism. The Atlas ...

10. Particle Engineering
(Pharmaceuticals/Pharmaceuticals)

... PRT, for manufacturing of Advanced Pharmaceutical Ingredients (APIs). The control of the crystal particle size of APIs is necessary when the final product performance is reliant upon having well-defined ...

11. DISCUS: Dispersive Crystallization with Ultrasound for Manufacture of Mesoscopic Particles
(technology/Technology)

... optional feed API solution is fed slowly into the flow cell whereby flow rates are often over 100:1. This leads to rapid dispersion and crystallization of micron and sub-micron sized particles which can ...

12. Inhalation
(Pharmaceuticals/Pharmaceuticals)

Why should we bother to engineer particles? Formulation performance is more than just about particle size. APIs are in essence performance chemicals and it is size, morphology, surface energy, and critically ...

13. Sonocrystallization
(technology/Technology)

... be applied in secondary manufacture of pharmaceutical ingredients and lends itself to polymorphic systems. By controlling nucleation, we can take control of, and improve, crystal size distribution, morphology, ...

14. Pharmaceutical Manufacture
(Pharmaceuticals/Pharmaceuticals)

... process. This allows focus on controlling the crystal growth via the residence time in the crystallizer. We have used this combined approach to influence crystal size distribution, assist in morphological ...

15. Ultrasonic Processing
(Engineering/Engineering)

... liquid, usually through contact with tiny bubbles inside the liquid, to generate cavitation.   This occurs when a succession of waves act to grow the tiny bubble to a size at which it becomes unstable ...

16. Technology
(technology/Technology)

... size of APIs is necessary when the final product performance is reliant upon having well defined and engineered mesoscopic particles, such as in the pharmaceutical and agrochemical industries. The size ...

17. Capabilities
(About us/about us)

... and investigation and can take the form of in-house crystallization and particle engineering studies looking at: * Polymorphism, habit and crystal size selection * Production of micro and ...

18. SAX Particle Engineering
(technology/Technology)

The control of crystal particle size of active pharmaceutical ingredients (APIs) is necessary where the final product performance is reliant upon having well defined and engineered mesoscopic particles. ...

19. New SonoLab Development Suite Launched
(News/Latest)

... allows chemists to control particle size, morphology and polymorphs. This results in higher quality crystalline materials with improved physicochemical properties and formulation performance. Designed ...

20. Prosonix and Aeropharm Announce Agreement
(News/Latest)

... report, the market size for inhaled medicines is expected to rise to $58 billion in 2012.  With a significant portion of these revenues available for near term generic substitution, and inhaled drug delivery ...